Search results
Early blood glucose control for people with type 2 diabetes
Digital Journal· 3 days agoThe data drawn from UKPDS represents the largest clinical evidence relating to diabetes yet...
Preventative drug providing hope for potential Type 1 diabetes patients in Colorado
CBS News· 6 days agoDoctors at the Barbara Davis Center for Diabetes are encouraged by a relatively new treatment that...
Diabetes drug recommended to treat obesity on the NHS
Press Association News via AOL· 1 day agoThe type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS....
7-Day No-Sugar, High-Protein, Anti-Inflammatory Meal Plan for Better Blood Sugar, Created by a...
Eating Well via Yahoo News· 3 days agoEatingWell Reviewed by Dietitian Maria Laura Haddad-GarciaReviewed by Dietitian Maria Laura...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 19 hours agoThey said the findings suggest the class of drugs act in a way that directly prevents cancer. Ozempic is prescribed to treat type 2 diabetes but can also...
Here Are 3 More Reasons to Be Bullish on Ozempic and Novo Nordisk Stock
Motley Fool via Yahoo Finance· 23 hours agoNovo Nordisk's (NYSE: NVO) type 2 diabetes drug Ozempic is a sensation, and it's no surprise why. In...
Genetic link between diabetes and gut health could offer treatment solutions
Medical Xpress· 6 days agoResearchers at Edith Cowan University's (ECU's) Center for Precision Health have uncovered a...
Diabetes drug metformin may be as safe as insulin during pregnancy
Medical News Today· 2 days agoResearchers have concluded that the oral diabetes medication metformin is just as safe for babies...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 20 hours agoThe Evolution of GLP-1 Medications The U.S. Food & Drug Administration (FDA) approved the first...
Insurance often denies GLP-1 medications for teens with type 2 diabetes, obesity
Medical Xpress· 4 days agoHealth insurance companies often deny coverage for new medications that treat children and teens...
